Functional analysis of E2-mediated repression of the HPV18 P105 promoter
- PMID: 1645591
Functional analysis of E2-mediated repression of the HPV18 P105 promoter
Abstract
Transcription of the transforming genes E6 and E7 of the human papillomavirus type 18 (HPV18) can be repressed by the product of the E2 open reading frame. Mutations were introduced in the cis-responsive elements upstream from the E6 and E7 transcriptional promoter, P105. The effect of these mutations in the absence or presence of E2 was examined in the human cervical carcinoma cell line C33, transfected with expression plasmids. In the presence of HPV18 E2, repression was relieved only when both of the two E2 binding motifs, immediately proximal to the P105 TATA box, were mutated. Mutation of a third E2 binding site, 110 nucleotides upstream of the TATA box, led to a slight but consistent activation in the presence of the full-length E2. Therefore, three E2 binding sites appear to be involved in the negative regulation of the P105 promoter by HPV18 E2. In the presence of the BPV1 E2 protein, only the E2 binding site most proximal to the promoter TATA box was involved in the P105 repression. The comparative analysis of the in vitro and in vivo properties of the human and bovine E2 proteins on the HPV18 P105 promoter provides new insights into the mechanism of transcriptional repression, which appears to involve steric hindrance at the site of transcriptional initiation.
Similar articles
-
Different arrangement of human papillomavirus E2 binding sites distinguishes cutaneous types from those associated with mucosal lesions.Arch Med Res. 1996 Autumn;27(3):389-94. Arch Med Res. 1996. PMID: 8854400
-
Effect of BPV1 E2-mediated inhibition of E6/E7 expression in HPV16-positive cervical carcinoma cells.Gynecol Oncol. 2001 Feb;80(2):168-75. doi: 10.1006/gyno.2000.6053. Gynecol Oncol. 2001. PMID: 11161855
-
A new cellular factor recognizes E2 binding sites of papillomaviruses which mediate transcriptional repression by E2.Virology. 2002 Feb 1;293(1):103-17. doi: 10.1006/viro.2001.1231. Virology. 2002. PMID: 11853404
-
The papillomavirus E2 protein: a factor with many talents.Trends Biochem Sci. 1991 Nov;16(11):440-4. doi: 10.1016/0968-0004(91)90172-r. Trends Biochem Sci. 1991. PMID: 1663669 Review.
-
The papillomavirus E2 regulatory proteins.J Biol Chem. 1991 Oct 5;266(28):18411-4. J Biol Chem. 1991. PMID: 1655748 Review. No abstract available.
Cited by
-
Multiple HPV integration mode in the cell lines based on long-reads sequencing.Front Microbiol. 2023 Dec 15;14:1294146. doi: 10.3389/fmicb.2023.1294146. eCollection 2023. Front Microbiol. 2023. PMID: 38169727 Free PMC article.
-
A new E6/P63 pathway, together with a strong E7/E2F mitotic pathway, modulates the transcriptome in cervical cancer cells.J Virol. 2007 Sep;81(17):9368-76. doi: 10.1128/JVI.00427-07. Epub 2007 Jun 20. J Virol. 2007. PMID: 17582001 Free PMC article.
-
Mechanisms of human papillomavirus E2-mediated repression of viral oncogene expression and cervical cancer cell growth inhibition.J Virol. 2000 Apr;74(8):3752-60. doi: 10.1128/jvi.74.8.3752-3760.2000. J Virol. 2000. PMID: 10729150 Free PMC article.
-
Human papillomavirus type 16 E2 protein has no effect on transcription from episomal viral DNA.J Virol. 2003 Feb;77(3):2021-8. doi: 10.1128/jvi.77.3.2021-2028.2003. J Virol. 2003. PMID: 12525636 Free PMC article.
-
Multiple regions of E6AP (UBE3A) contribute to interaction with papillomavirus E6 proteins and the activation of ubiquitin ligase activity.PLoS Pathog. 2020 Jan 23;16(1):e1008295. doi: 10.1371/journal.ppat.1008295. eCollection 2020 Jan. PLoS Pathog. 2020. PMID: 31971989 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources